期刊文献+

羟氯喹联合甲氨蝶呤治疗类风湿关节炎临床观察 被引量:5

Clinical Observation of Hydroxychloroquine Combined with Methotrexate in the Treatment of Rheumatoid Arthritis
下载PDF
导出
摘要 目的探讨羟氯喹联合甲氨蝶呤治疗类风湿关节炎(RA)的临床疗效,以及对患者骨代谢、炎性因子、D-二聚体(D-D)、纤维蛋白原(Fib)水平的影响。方法选取医院风湿免疫科2016年7月至2017年7月收治的RA患者180例,按随机数字表法分为对照组和联合组,各90例。两组患者均予甲氨蝶呤片口服,联合组患者加服羟氯喹片。两组均治疗24周。结果联合组总有效率为81.11%,显著高于对照组的66.67%(P<0.05);联合组患者治疗后的总Ⅰ型胶原氨基端延长肽、骨钙素N端中分子水平均显著高于对照组,β-胶原降解产物水平、白细胞介素6、肿瘤坏死因子-α、粒细胞集落刺激因子、D-D及Fib水平均显著低于对照组(P<0.05);联合组与对照组不良反应发生率相当(33.33%比34.44%,P>0.05)。结论羟氯喹联合甲氨蝶呤治疗RA,可改善患者的骨代谢,降低机体炎性反应水平,减少D-D及Fib含量。 Objective To investigate the clinical efficacy of hydroxychloroquine combined with methotrexate in the treatment of patients with rheumatoid arthritis(RA)and the effect on bone metabolism,inflammatory factors,D-Dimer(D-D)and fibrinogen(Fib).Methods A total of 180 patients with RA admitted to our hospital from July 2016 to July 2017 were selected and divided into the control group and the combined group according to the random number table method,90 cases in each group.The patients in the two groups were given Methotrexate Tablets,on this basis,the patients in the combined group were given Hydroxychloroquine Sulfate Tablets.Both groups were treated for 24 weeks.Results The total effective rate of the combined group was 81.11%,which was significantly higher than 66.67%of the control group(P<0.05).After treatment,the levels of propeptide of typeⅠprocollagen(T-PINP)and N-mid osteocalcin(N-MID)in the combined group were significantly higher than those in the control group,while the levels ofβ-C-terminal telopeptide of typeⅠcollagen(β-CTX),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),macrophage-stimulating factor(M-CSF),D-D and Fib in the combined group were significantly lower than those in the control group(P<0.05).The incidence of adverse reactions in the combined group was similar to that in the control group(33.33%vs.34.44%,P>0.05).Conclusion Hydroxychloroquine combined with methotrexate in the treatment of RA can improve bone metabolism,reduce the inflammatory reaction and the contents of D-D and Fib.
作者 任占芬 郑学军 罗寰 杨金良 阎敏娜 REN Zhanfen;ZHENG Xuejun;LUO Huan;YANG Jinliang;YAN Minna(The First Affiliated Hospital of Hebei North University,Zhangjiakou,Hebei,China 075000)
出处 《中国药业》 CAS 2021年第16期102-104,共3页 China Pharmaceuticals
基金 河北省医学科学研究重点课题[20170821]。
关键词 类风湿关节炎 羟氯喹 甲氨蝶呤 炎性因子 骨代谢 临床疗效 rheumatoid arthritis hydroxychloroquine methotrexate inflammatory factors bone metabolism clinical efficacy
  • 相关文献

参考文献15

二级参考文献81

  • 1侯景伦,张北北,曹子青.风湿骨痛宁胶囊药效学实验研究[J].中成药,1995,17(10):27-28. 被引量:3
  • 2王娅南,杨林,孙天英.转化生长因子-β_1与类风湿性关节炎[J].华北煤炭医学院学报,2006,8(4):459-462. 被引量:2
  • 3侯勇,张奉春,黄烽,吴东海,鲍春德,倪立青,姚晨.Infliximab治疗类风湿关节炎的随机双盲平行多中心临床试验[J].中华风湿病学杂志,2006,10(11):658-663. 被引量:34
  • 4张亦军,赛佳明.类风湿关节炎危险因素研究进展[J].齐鲁医学杂志,2007,22(6):556-557. 被引量:6
  • 5St Clair EW;Pisetsky DS;Haynes BF;王吉波; 吕振华.类风湿关节炎[M]{H}北京:人民卫生出版社,200813-16.
  • 6Aletaha D,Neogi T,silman AJ. 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initi}Rive[J].{H}ARTHRITIS AND RHEUMATISM,2010,(09):2569-2581.
  • 7Saudan M,Saudan P,Perneger T. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement:a prospective randomised trial[J].{H}JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME,2007,(02):155-159.
  • 8van der Heijde D,Klareskog L,RodriguezValverde V. Comparison of etanercept and methotrexate,alone and combined,in the treatment of rheumatoid arthritis:two-year clinical and radiograhpic results from the TEMPO study,a double-blind,randomized trial[J].{H}ARTHRITIS AND RHEUMATISM,2006,(04):1063-1074.
  • 9van der Heijde D,Klareskog L,LandewP R. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis[J].{H}ARTHRITIS AND RHEUMATISM,2007,(12):3928-3939.
  • 10Horiuchi T,Mitoma H,Harashima S. Transmembrane TNF-alpha:structure,function and interaction with anti-TNF agents[J].{H}Rheumatology(Oxford),2010,(07):1215-1228.

共引文献223

同被引文献63

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部